VARIZIG 125 [iU]/1.2mL
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN · INJECTION, SOLUTION · Kamada Ltd.
VARIZIG is a injection, solution containing human varicella-zoster immune globulin at 125 [iU]/1.2mL, taken intramuscular. Manufactured by Kamada Ltd..
Key Facts
- Brand Name
- VARIZIG
- Generic Name
- HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN
- NDC Code (Product)
49591-126- Manufacturer
- Kamada Ltd.
- Strength
- 125 [iU]/1.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125430
- Marketing Start
- 03/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is VARIZIG used for?
VARIZIG contains HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is VARIZIG a controlled substance?
VARIZIG is not classified as a controlled substance by the DEA.
What is the generic name for VARIZIG?
The generic name for VARIZIG is HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN. There are no other listed brand versions of HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN.
What is the NDC code for VARIZIG 125 [iU]/1.2mL?
The NDC (National Drug Code) for VARIZIG 125 [iU]/1.2mL is 49591-126, listed by Kamada Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)